Bakhu Holdings reported zero Revenue for the three months ended January 31, 2025, while total liabilities stood at $11,570,184 and cash and cash equivalents were zero. The figures matter to investors because current liabilities were $3,289,129 and the Balance Sheet also showed a $295 bank overdraft.

Key Highlights

  • Bakhu Holdings recorded $0 in net revenues for the quarter, matching the comparable period.
  • Total liabilities stood at $11,570,184 at January 31, 2025.
  • Common shares issued and outstanding totalled 301,302,983 at the reporting date.

Bakhu Holdings, Corp. generated $0 in net revenue during the three months ended January 31, 2025, unchanged from the comparable period. The Business focuses on plant-based cannabis products for medical, food additive and recreational uses. Operating expenses included consulting fees, professional fees and other operating expenses, while interest expense was also recorded. Cash and cash equivalents were zero at the reporting date.

Quarterly Revenue Remains Absent

Bakhu recorded no net revenues in either of the two comparable three-month periods. Consulting fees, professional fees, other operating expenses and interest expense affected the quarter’s results. The filing also identifies the business focus as plant-based cannabis products produced through plant cell-extraction and replication technology under a technology license.

Current Liabilities Reach $3,289,129

Current liabilities totalled $3,289,129 at January 31, 2025. The balance included a $295 bank overdraft, $2,103,816 in accounts payable, $775,018 in accrued interest, a $260,000 settlement Liability due to a leasing company and a $150,000 current portion of notes payable to related parties. Non-current liabilities comprised $7,560,890 in notes payable to related parties and $720,165 in notes payable to third parties. Total non-current liabilities were $8,281,055, bringing total liabilities to $11,570,184.

No Cash On Balance Sheet

Cash and cash equivalents were $0, and total current Assets were also $0 at January 31, 2025. Total assets stood at $0. The balance sheet showed additional paid-in Capital of $40,411,525 and an accumulated Deficit of $52,283,012. Stockholders’ Equity was reported as a deficit of $11,570,184. Common stock had a Par Value of $0.001, with 301,302,983 shares issued and outstanding.

Equity And Debt Structure

Bakhu had 500,000,000 common shares authorized and 50,000,000 Preferred Shares authorized. The common stock balance was $301,303, while the preferred stock balance was $0.